Clinical Evidence for the Stereotaxis Niobe® Magnetic Navigation System: Advantages of Electrophysiology (EP) Ablation
Download the Full Clinical Evidence Summary
Approximately 180 leading Global hospitals have adopted the Niobe™ Magnetic Navigation System, (MNS) for EP ablation. The current Niobe MNS is a 4th generation system, and an evolution from earlier Stereotaxis clinical systems. To date, over 80,000 EP procedures have been performed in magnetic navigation labs which have led to excellent clinical outcomes. Of the 259 total peer-reviewed scientific publications highlighting remote magnetic navigation technology, 238 publications discuss its use in cardiac EP procedures, and are featured in peer reviewed journals such as the Journal of Cardiovascular Electrophysiology, PACE, Europace, the Journal of American College of Cardiology, and the Journal of Interventional Cardiac Electrophysiology. This clinical research, resulting journal publications and physician advocacy have led to greater market access, regulatory and reimbursement support, and provider adoption.
Research with Stereotaxis’ innovations and published papers have established overwhelming evidence supporting magnetic navigation’s clinical benefits, including:
- Improved long-term patient clinical outcomes (complex left atrial [CLA] arrhythmia, ventricular tachycardia [VT], and congenital heart disease treatment)
- Procedural efficiency through reduced treatment times and improved patient work flow
- Excellent patient safety (through decreased procedure-related complication rates)
- Reduced long-term cancer risks by lowering X-ray fluoroscopic radiation for physicians, laboratory staff and patients (especially for the vulnerable pediatric population)